SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-009191
Filing Date
2020-08-05
Accepted
2020-08-04 17:56:07
Documents
58
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q xncr-20200630x10q.htm   iXBRL 10-Q 1970489
2 EX-10.1 xncr-20200630xex10d1.htm EX-10.1 22728
3 EX-31.1 xncr-20200630xex31d1.htm EX-31.1 17294
4 EX-31.2 xncr-20200630xex31d2.htm EX-31.2 17279
5 EX-32.1 xncr-20200630xex32d1.htm EX-32.1 9303
  Complete submission text file 0001558370-20-009191.txt   7884308

Data Files

Seq Description Document Type Size
6 EX-101.SCH xncr-20200630.xsd EX-101.SCH 38995
7 EX-101.CAL xncr-20200630_cal.xml EX-101.CAL 54625
8 EX-101.DEF xncr-20200630_def.xml EX-101.DEF 160894
9 EX-101.LAB xncr-20200630_lab.xml EX-101.LAB 443331
10 EX-101.PRE xncr-20200630_pre.xml EX-101.PRE 318320
11 EXTRACTED XBRL INSTANCE DOCUMENT xncr-20200630x10q_htm.xml XML 1650933
Mailing Address 111 WEST LEMON AVE MONROVIA CA 91016
Business Address 111 WEST LEMON AVE MONROVIA CA 91016 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

IRS No.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36182 | Film No.: 201074557
SIC: 2834 Pharmaceutical Preparations